Labshake search
Citations for Invivogen :
101 - 150 of 1332 citations for 3 3 2 3 Dimethyl indol 1 yl 2 hydroxy propylamino propan 1 ol since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Synthetic Biology 2024Quote: ... then selected with 2 µg/mL puromycin (InvivoGen, ant-pr-1). In each round of selection ...
-
bioRxiv - Cancer Biology 2024Quote: ... followed by a selection using 1-2 µg/mL puromycin (InvivoGen).
-
bioRxiv - Bioengineering 2024Quote: ... Alum samples were prepared by performing a 1:1 dilution of 2% Alhydrogel® adjuvant (InvivoGen) with stock solutions of 400 μg/mL endotoxin-free OVA ...
-
bioRxiv - Molecular Biology 2020Quote: ... Disease was induced between 6 and 10 weeks of age using 3 mg curdlan (InvivoGen) administered by intraperitoneal injection ...
-
bioRxiv - Immunology 2023Quote: ... The Class C CpG ODN_2395 sequence (5’-TCGTCGTTTTCGGCGCGCGCCG-3’) was obtained from Invivogen (#tlrl-2395). We used the crystal structure of mouse TLR9 extracellular domain (TLR9 ECD ...
-
bioRxiv - Immunology 2024Quote: ... BMDCs were pretreated for 3 hours with either TLR4 inhibitor TAK-242 (InvivoGen, #tlr-cli95) at three different concentrations (1.25 μM ...
-
bioRxiv - Cancer Biology 2021Quote: ... for 10 days or 2 μg/mL puromycin (InvivoGen; #ant-pr-1) for 4 days to generate stable cell lines.
-
bioRxiv - Biochemistry 2022Quote: ... cells were selected with 2 μg/mL puromycin (Invivogen: ant-pr-1).
-
bioRxiv - Physiology 2023Quote: ... and 1% normocin antibiotic (ant-nr-2, Invivogen, San Diego, CA, USA) at 20% oxygen (5% CO2 ...
-
bioRxiv - Immunology 2024Quote: ... and Incomplete Freund’s Adjuvant (IFA, 1:2 dilution, InvivoGen, cat# vac-ifa). For fluorescent in vivo imaging studies DNA-adjuvants were 3’-conjugated to Cy5 fluorophore (AxoLabs) ...
-
bioRxiv - Microbiology 2024Quote: ... samples were mixed with a 1/10th volume of Alhydrogel (2%, InvivoGen) and agitated for 30 min ...
-
RORγt-dependent antigen-presenting cells direct regulatory T cell-mediated tolerance to food antigenbioRxiv - Immunology 2024Quote: ... with intraperitoneal injections of 100 μg of OVA mixed with 1 mg of Alum (1:1; Alhydrogel® adjuvant 2%; vac-alu-50; InvivoGen). Seven days after the final sensitization ...
-
bioRxiv - Immunology 2023Quote: ... and absorbance levels detected at 655 nm after 3 h incubation with QUANTI-Blue Solution (Invivogen). The absorbances of RAW-Blue assay were normalized to absorbance intensity at the highest and lowest dilutions ...
-
bioRxiv - Bioengineering 2024Quote: ... Antigens were injected intramuscularly at a dose of 3 μg and 5 μg with AddaVax (InvivoGen) in 100 μL for prime and boost ...
-
bioRxiv - Immunology 2021Quote: ... in a final volume of 100 µL X-VIVOTM-15 + 2% HS + 1 µg.mL-1 poly(I:C) (tlrl-picw, Invivogen). After 3 h ...
-
bioRxiv - Microbiology 2023Quote: ... Omicron BA.1 and Omicron BA.2 were purchased from InvivoGen (Toulouse, France). SARS-CoV-2pp were generated as previously described ...
-
bioRxiv - Cancer Biology 2024Quote: ... A positive control of 2 µg/ml of Puromycin (InVivoGen, ant-pr-1) was included ...
-
bioRxiv - Immunology 2024Quote: ... AS03-like squalene-based adjuvant (AddaS03, 1:2 dilution, InvivoGen, cat# vac-as03), Monophosphoryl Lipid A (MPLA ...
-
bioRxiv - Biochemistry 2024Quote: ... cells were covered with selection media comprised of DMEM + 10 % HI FBS + 1% PS and 2 μg/mL puromycin (Invivogen 58-58-2). Selection media was replaced every 48 h until control WT cells were completely dead ...
-
bioRxiv - Microbiology 2023Quote: ... The cells were cultured for 2 weeks in the presence of 1 µg/mL puromycin (ant-pr-1, InvivoGen). The cells were single-cell-cloned using a limiting dilution method ...
-
bioRxiv - Immunology 2023Quote: ... with 50 μg of the Toll-like receptor (TLR)3 agonist polyinosinic-polycytidylic acid [poly (I:C)] (InvivoGen), 50 μg of the TLR7 agonist imiquimod (InvivoGen) ...
-
bioRxiv - Systems Biology 2022Quote: ... and cells were selected with 2 µg/mL puromycin (Invivogen, catalog # ant-pr-1) 96 hours post-transfection for 3 days ...
-
bioRxiv - Cell Biology 2021Quote: ... TANK-binding kinase 1 (TBK1) and IκB kinase ε (IKKε; BX795, 2 μM; Invivogen); receptor for advanced glycation end products (RAGE ...
-
bioRxiv - Immunology 2023Quote: ... and positive cells were selected using 2 μg/mL puromycin (InvivoGen, ant-pr-1) for GFP and mCherry or 1 mg/mL G-418 solution (Roche ...
-
bioRxiv - Cancer Biology 2022Quote: ... The infected cultures were selected by sorting of RFP+ cells 3 days after transduction and expanded in supplemented media with puromycin (2.5µg/ml; InvivoGen) and blasticidin (1µg/ml ...
-
bioRxiv - Developmental Biology 2023Quote: ... Clones were selected with 3 μg/mL (and maintained with 1μg/mL) of Puromycin (Invivogen, #ant-pr-5b).
-
bioRxiv - Immunology 2022Quote: ... 2 ug/mL Pam3CSK4 (TLR1/2 agonist, Invivogen), and 1 ug/mL FSL-1 (TLR2/6 agonist ...
-
bioRxiv - Bioengineering 2024Quote: ... incubated overnight in R10 medium with 60 IU mL-1 IL-2 and 100 µg mL-1 Normocin™ antibiotic (Invivogen, CAT#ANT-NR-1). The next day ...
-
bioRxiv - Neuroscience 2021Quote: ... resiquimod (2 mg/kg of a 1 mg/ ml solution in PBS, Invivogen tlrl-r848), were administered subcutaneously on E12.5 between 9:00-11:00 am and their conditions were monitored to ensure that there was no sign of any severe sickness symptoms or abnormalities.
-
bioRxiv - Molecular Biology 2024Quote: ... cells were selected with complete media containing 2 μg/ml puromycin (InvivoGen, ant-pr-1) for 10 days and maintained with 0.5 μg/mL Puromycin ...
-
bioRxiv - Immunology 2024Quote: ... 50 μM 2-mercaptoethanol (Fisher; 31350010) and 100 μg/ml Normocin (InvivoGen; ant-nr-1)) ...
-
bioRxiv - Immunology 2022Quote: ... N = 3) were immunized with a mixture of 50 μg each of H1ssF and H10ssF formulated with AddaVax (Invivogen) in 1 ml via intramuscular route at weeks 0 ...
-
bioRxiv - Immunology 2023Quote: ... Adenosine 5’-triphosphate disodium salt (ATP, CAS: 987-65-5), poly(dA:dT), and nigericin (Nig, CAS: 28643-80-3) were from InvivoGen. Cross linker disuccinimidyl suberate (DSS ...
-
bioRxiv - Genetics 2024Quote: ... Selection for blasticidin-expressing infected cells was performed for 3 to 4 days using 3.0 µg/mL blasticidin (InvivoGen), which was added on the 3rd day post-infection.
-
bioRxiv - Bioengineering 2021Quote: ... and 2 µl/ml primicin (Ant-pm-2, InvivoGen) at 37°C for 19 hours.
-
bioRxiv - Bioengineering 2022Quote: ... and 2 μl/ml primocin (Ant-pm-2, InvivoGen) at 37°C for 19 hours ...
-
bioRxiv - Pathology 2020Quote: ... FIV was diluted in PBS to 133μg/mL Coronavirus-specific protein and mixed 1:1 in 2% Alhydrogel (Invivogen vac-alu-250) to give a final concentration of 66.7μg/mL in 1% Alhydrogel ...
-
bioRxiv - Cell Biology 2023Quote: ... and if required relevant selection antibiotics (hygromycin 200 µg/ml ; InvivoGen, ant-hg-1 ; puromycin 2 µg/ml, InvivoGen, ant-pr-1). Im95m cells were routinely maintained in DMEM supplemented with 10% FBS ...
-
bioRxiv - Immunology 2022Quote: ... 2 mM (peritoneal macrophages) ATP or 50 µM (THP-1 differentiated macrophages) R837 (InvivoGen, tlrl-imqs) for 30-60 min ...
-
bioRxiv - Microbiology 2023Quote: ... Envelope defective virus was pseudotyped with HU-1 SARS-CoV-2 Spike protein (pLV-Spike, Invivogen) and used for single round infection assays ...
-
bioRxiv - Microbiology 2023Quote: ... B.1.1.529/BA.1 SARS-CoV-2 spike plasmid (plv-spike-v11) was obtained from InvivoGen and subcloned into pcDNA3.1-puro ...
-
bioRxiv - Cancer Biology 2023Quote: ... Antibiotic selection was applied two days after transfection (2 μg/mL puromycin (#ant-pr-1, Invivogen) for 3 days).
-
bioRxiv - Cell Biology 2022Quote: ... Infected cells were selected by incubation in medium containing 200 µg/mL hygromycin B Gold or 3 µg/mL blasticidin S (InvivoGen) for 4 d ...
-
bioRxiv - Genetics 2020Quote: ... Cells were lysed using passive lysis buffer and the activity of the enhancer assessed using a Lucia QUANTI-Luc Gold Assay #3 luciferase kit (InvivoGen). Because of clear evidence of the response of the pGL4.74 Renilla normalisation control plasmid to PMA treatments and co-transfection with the EGR1 expression vector Lucia activity levels were normalised against quantitative PCR (qPCR ...
-
bioRxiv - Immunology 2021Quote: ... At the time of seeding 3 tumor fragments were additionally treated with either vehicle control (endotoxin-free water) or CpG ODN 2006 (InvivoGen) at 0.5ug/mL ...
-
bioRxiv - Cell Biology 2024Quote: ... Infected cells were selected by incubation in medium containing 3 µg/mL blasticidin S or 200 µg/mL hygromycin B Gold (InvivoGen) for 4 d.
-
bioRxiv - Microbiology 2023Quote: ... S10-3 ITGB1 KO cells were transduced with pWPI-ITGB1 and selected in cDMEM supplemented with 400 μg/ml G418 (Invivogen). S10-3 WT cells were transduced with pTRIPZ-Rab5/7/11-GFP or EGFP-LAMP1 and selected in cDMEM supplemented with 2 μg/ml puromycin (Invivogen).
-
bioRxiv - Immunology 2023Quote: ... mice were immunized with 50 μg (day 3 analysis) or 100 μg (day 7 analysis) chicken ovalbumin (OVA) protein (InvivoGen) in PBS ...
-
bioRxiv - Immunology 2023Quote: ... alongside 100 μg mIgG1 anti-CD40 mAb (3/23, mouse IgG1 generated in-house as described previously[29, 30]) and the indicated doses of DMXAA(Invivogen), ADU-S100 was obtained from Oxeltis(Montpellier ...
-
bioRxiv - Molecular Biology 2024Quote: ... 293T and Calu-3 cells were transduced with murine leukemia virus-based transduction vectors encoding ACE2 and subsequently selected with puromycin (Invivogen), resulting in cell lines that stably expressed ACE2 ...